Peripheral T-Cell Lymphoma (PTCL)

Peripheral T-cell Lymphoma (PTCL) is a sub-type of non-Hodgkins lymphoma. It is an aggressive, high-grade type of cancer. It generally has a poor prognosis, but may respond better to treatment than indolent, low-grade lymphoma.

Incidence

Only 15% of non-Hodgkins lymphoma patients have a PTCL subtype, the disease is more common in adults than children. Because Peripheral T-cell Lymphoma is aggressive, treatment is imperative to quality of life and survival.

Treatment

Currently, the treatments available for PTCL are chemotherapy, radiotherapy, steroids, and bone marrow transplant. One treatment has been approved by the FDA for initial treatment of PTCL, although there currently is no gold-standard treatment for use in recurring PTCL.

Clinical Trials

Clinical trials for recurring PTCL should be seen as an treatment option for as they allow patients to receive treatment which have been established as safe for humans, but are still undergoing studies to see how well they work.

Follow this link to identify a conveniently located cancer treatment center and begin the process of enrollment.

Belinostat

Belinostat is one drug being offered in clinical trials for PTCL. Common side effects of belinostat therapy include fatigue, nausea and vomiting. However, it has shown no toxicity to patients’ bone marrow which is the biggest limitation in of other successful chemotherapy combinations.

More Articles

More Articles

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

When you consider that the adult human body has anywhere from 300 to 700 lymph nodes, the better question might not be where ARE they located, but...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Intravascular lymphoma is a subtype of 'Lymphoma', an umbrella term that loosely refers to several dozen...

While the average lifespan for hamsters is only about 2.5 years, and they are therefore less prone to long-term illnesses, it is possible for a...

Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Lymphoma is a life-threatening disease, but is very treatable in most cases. The 5-year survival for patients diagnosed with non-Hodgkin's...

T cell lymphoma treatment options for these cancers are not especially effective and there is no absolute consensus about optimal treatments for...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid...